Orserdu (elacestrant): A Magic Drug for Advanced Breast Cancer
Orserdu (elacestrant) is an oral medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of a specific type of advanced breast cancer. It is designed for postmenopausal women and adult men with estrogen receptor (ER)-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer that has progressed after at least one line of […]
Orserdu (elacestrant): A Magic Drug for Advanced Breast Cancer Read More »


